logo

FOLD

Amicus Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.56 / 10
Netural

Fund‑flow score is 6.96/10, showing overall positive inflows, especially from block and extra‑large investors, though medium and large flows turn negative. Analyst coverage is limited to one neutral rating, yielding a mixed sentiment environment.

FundamentalSentiment(5.56)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

0%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-01-22
InstitutionJefferies
Times predicted1
Historical Win Rate100.0%
What is the market sentiment for FOLD?
  • FOLD holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.56/10 (Netural).